TIME TO SELL RGC STOCK$RGC rally now looks exhausting, price begins to lose momentum and RSI indicates that stock is overbought and needs re-evaluation.
−0.33 USD
−4.30 M USD
0.00 USD
1.46 M
About Regencell Bioscience Holdings Limited
Sector
CEO
Yat-Gai Au
Headquarters
Hong Kong
Website
Founded
2014
FIGI
BBG00ZS40360
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Waiting for a crazy brekout Obviously, NASDAQ:RGC is a crazy beast on steroids. Because it's ultra low float :) We've seen crazy moves already and now price is in consolidation stage. AWWAP formed since IPO serves as support and the price is coming closer to 10day SMA, what should also act as additional factor for going long
RGC long, taking profits at 34$post-market scanner showed me RGC as big % mover, entry in pre-market on the new high break at 24$
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RGC is 6.92 USD — it has decreased by −4.55% in the past 24 hours. Watch Regencell Bioscience Holdings Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Regencell Bioscience Holdings Limited stocks are traded under the ticker RGC.
RGC stock has risen by 8.12% compared to the previous week, the month change is a 47.23% rise, over the last year Regencell Bioscience Holdings Limited has showed a −54.44% decrease.
RGC stock is 30.65% volatile and has beta coefficient of −5.65. Track Regencell Bioscience Holdings Limited stock price on the chart and check out the list of the most volatile stocks — is Regencell Bioscience Holdings Limited there?
Today Regencell Bioscience Holdings Limited has the market capitalization of 90.05 M, it has increased by 50.87% over the last week.
Yes, you can track Regencell Bioscience Holdings Limited financials in yearly and quarterly reports right on TradingView.
RGC net income for the last half-year is −2.24 M USD, while the previous report showed −2.07 M USD of net income which accounts for −8.16% change. Track more Regencell Bioscience Holdings Limited financial stats to get the full picture.
No, RGC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 12.00 employees. See our rating of the largest employees — is Regencell Bioscience Holdings Limited on this list?
Like other stocks, RGC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Regencell Bioscience Holdings Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Regencell Bioscience Holdings Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Regencell Bioscience Holdings Limited stock shows the sell signal. See more of Regencell Bioscience Holdings Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.